Topic: United States
PARIS (Reuters) - French drugmaker Sanofi said a late-stage study of its lixisenatide drug in combination with Lantus insulin showed a significant improvement in blood sugar levels and a beneficial effect on body weight in type 2 diabetes patients.Lixisenatide, which will be ...
CHICAGO (Reuters) - The U.S. Food and Drug Administration issued new guidelines to medical device makers developing a potentially revolutionary device for type 1 diabetes, saying they should speed its delivery to patients.The guidelines reflect months of behind-the-scenes negotiations with patient advocates, ...
CHICAGO (Reuters) - The U.S. Food and Drug Administration issued new guidelines on Thursday for the development of a potentially revolutionary device to treat type 1 diabetes that will give manufacturers 'maximum flexibility' in getting it to U.S. patients.The guidelines reflect months ...
CHICAGO (Reuters) - It's a dream of medical science that looks tantalizingly within reach: the artificial pancreas, a potential breakthrough treatment for the scourge of type 1 diabetes.Meant to mimic the function of a real pancreas, the artificial version is a complex ...
HONG KONG (Reuters) - Mobile technologies will be increasingly deployed to enable people in Asia to monitor and manage their health, with the market expected to hit $7 billion by 2017, an industry official said.In parts of Europe and the United States, ...
HONG KONG (Reuters) - Mobile technologies will be increasingly deployed to enable people in Asia to monitor and manage their health, with the market expected to hit $7 billion by 2017, an industry official said.In parts of Europe and the United States, ...
(Reuters) - One in 10 adults will have diabetes by 2030, posing a huge challenge to healthcare systems around the world, according to a report on Monday.The number of people living with the disease is expected to soar to 552 million by ...
HONOLULU (Reuters) - Eli Lilly and Co has hit a tough spot with the pharmaceutical company's top treatment now facing competition from cheaper generic brands and the looming loss of patent protection on other drugs."It may be one of our most challenging ...
CHICAGO (Reuters) - Early, aggressive treatment of type 1 diabetes cut the risk of kidney disease in half in a study that followed a group of diabetics since the 1980s, U.S. researchers said on Saturday.The findings, published in the New England Journal ...
A drug known as sulodexide has failed to show any benefit toward halting kidney failure in people with diabetes and an international trial has been stopped early, a US medical journal said Thursday.The drug, once seen as a potentially promising treatment to ...
Photo Gallery
-
South Korea Koreas Clash
South Korean Foreign Minister Kim Sung-hwan, right, shakes hands with U.S ...AP News - -
Hawks Kings Basketball
Sacramento Kings forward Carl Landry, center, goes to the basket against Atlanta ...AP News - -
Blue Jackets Coyotes Hockey
Columbus Blue Jackets' R.J. Umberger (18) scores a goal against Phoenix ...AP News -
